Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects

NCT02264054 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: [14C]talsaclidine, oral
DRUG: [14C]talsaclidine, iv

Sponsor

Boehringer Ingelheim